Inhibitors targeting Stat3 or IL-6 could significantly attenuate the pneumonia induced by AC, expanding our understanding of angiostrongyliasis cantonensis and providing effective candidate targets for intervention in AC-induced pneumonia. Here, IL6 is linked to susceptibility to pneumonia measurement.